MELBOURNE (Reuters) - Australian flu drug maker Biota Holdings has agreed to take over U.S. firm Nabi Biopharmaceuticals to create a $258 million group and move to the United States, where investors value biotech research more highly than in Australia.
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/Pqz_7x-Pajc/us-biota-nabi-deal-idUSBRE83M0DK20120423
recent news save money travel make money best news online money
No comments:
Post a Comment